Kalus Sarah, King John, Lui Elaine, Gaillard Frank
Department of Radiology, 1st Floor, 1B Building, The Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia.
Department of Neurology, The Royal Melbourne Hospital, Parkville, Australia.
J Clin Neurosci. 2016 Jan;23:162-164. doi: 10.1016/j.jocn.2015.08.010. Epub 2015 Oct 2.
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive degenerative movement disorder resulting from a fragile X "premutation", defined as 55-200 CGG repeats in the 5'-untranslated region of the FMR1 gene. The FMR1 premutation occurs in 1/800 males and 1/250 females, with FXTAS affecting 40-45% of male and 8-16% of female premutation carriers over the age of 50. FXTAS typically presents with kinetic tremor and cerebellar ataxia. FXTAS has a classical imaging profile which, in concert with clinical manifestations and genetic testing, participates vitally in its diagnosis. The revised FXTAS diagnostic criteria include two major radiological features. The "MCP sign", referring to T2 hyperintensity in the middle cerebellar peduncle, has long been considered the radiological hallmark of FXTAS. Recently included as a major radiological criterion in the diagnosis of FXTAS is T2 hyperintensity in the splenium of the corpus callosum. Other imaging features of FXTAS include T2 hyperintensities in the pons, insula and periventricular white matter as well as generalised brain and cerebellar atrophy. FXTAS is an under-recognised and misdiagnosed entity. In patients with unexplained tremor, ataxia and cognitive decline, the presence of middle cerebellar peduncle and/or corpus callosum splenium hyperintensity should raise suspicion of FXTAS. Diagnosis of FXTAS has important implications not only for the patient but also, through genetic counselling and testing, for future generations.
脆性X相关震颤/共济失调综合征(FXTAS)是一种进行性退行性运动障碍,由脆性X“前突变”引起,该突变定义为FMR1基因5'-非翻译区有55 - 200个CGG重复序列。FMR1前突变在男性中发生率为1/800,在女性中为1/250,50岁以上的男性前突变携带者中40 - 45%、女性前突变携带者中8 - 16%会发生FXTAS。FXTAS通常表现为运动性震颤和小脑共济失调。FXTAS具有典型的影像学特征,与临床表现和基因检测相结合,对其诊断至关重要。修订后的FXTAS诊断标准包括两个主要影像学特征。“MCP征”指小脑中间脚T2高信号,长期以来一直被认为是FXTAS的影像学标志。最近胼胝体压部T2高信号也被纳入FXTAS诊断的主要影像学标准。FXTAS的其他影像学特征包括脑桥、岛叶和脑室周围白质T2高信号以及全脑和小脑萎缩。FXTAS是一种未被充分认识和误诊的疾病。对于不明原因震颤、共济失调和认知功能下降的患者,小脑中间脚和/或胼胝体压部高信号的出现应引起对FXTAS的怀疑。FXTAS的诊断不仅对患者很重要,而且通过遗传咨询和检测,对后代也很重要。